Unresectable Malignant Solid Neoplasm Active Not Recruiting Phase 1 Trials for Nivolumab (DB09035)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0110416 (Unresectable Malignant Solid Neoplasm) | Active Not Recruiting | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03502733 | Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma | Treatment |